08/20/2015 - 10:02am

Since the launch of Nexium 24HR in May of 2014, the brand has generated approximately $300 million, “making it one of the largest and most successful Rx-to-OTC switches,” Ian Read, Pfizer chairman and CEO, recently told analysts.

08/20/2015 - 10:02am

The big story in the digestives space continues to be the switch and launch of Pfizer’s Nexium 24HR. For the 52 weeks ended June 14, sales of Nexium 24HR across total U.S. multi-outlets reached $278.7 million and are still climbing, according to IRI.

08/20/2015 - 10:01am

Tylenol has retaken the OTC pain relief aisle with a vengeance. The brand is close to reclaiming the top spot among internal analgesic tablets behind Aleve and Advil and is growing at a 10% rate on a dollar base of more than $250 million. 

08/20/2015 - 10:01am

The top four best-selling internal analgesic brands — Advil, Aleve, Tylenol and Bayer — generate more than 40% of the overall $3.3 billion in internal analgesic tablet sales, according to IRI figures. But it’s the smaller niche external analgesic brands that are contributing a lot of incremental sales to the pain relief category.

08/20/2015 - 10:01am

Sales of OTC products are ramping up significantly with a $1.5 billion gain over the first six months of 2015. 

08/20/2015 - 9:58am

DSN has partnered with Competitive Promotion Report (CPR) and IRI to create a series of exclusive reports. This article highlights the market performance of major brands in the pain category for both the internal and external analgesic segments.

08/20/2015 - 9:57am

The National Association of Chain Drug Stores will host a Vision 2026 platform at the Total Store Expo this month in Denver. Here, DSN previews a few of the companies that will be participating in Vision 2026 by offering their perspectives on the changes ahead in retail and health care in the years to come.

08/19/2015 - 1:11pm

LeeAnn Weniger-Mandrillo operates a marketing firm focused on creating social media and marketing campaigns about drugs, alcohol, mental health and bullying.

08/19/2015 - 11:22am

Levy will provide key insights on the changing healthcare industry to advance the board's mission of helping consumers make more informed healthcare decisions.